Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

115 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Active, not recruiting

Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

NCT04279847

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +19 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Emory University-Winship Cancer Institute Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Active, not recruiting

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

NCT04378855

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Asl Di Asti, Ospedali Riuniti - Presidio Ospedaliero Cardinal G. Massaia - Sc Oncologia Asti, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia Bari, Italy
View all 25 locations
View Trial Details
Active, not recruiting

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

NCT04041050

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations
  • City of Hope /ID# 239769 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
  • UCLA /Id# 222784 Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

NCT03588078

Conditions
Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Bruno Quesnel Lille, France
  • Dr Pierre Peterlin and Pr Patrice Chevalier Nantes, France
  • Hôpital Archet 1 Nice, France
  • Hôpital Saint Louis - Hématologie Séniors Paris, France
View Trial Details
Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
View Trial Details

Related conditions